Short report: HIV protease inhibitors, indinavir or nelfinavir, augment antimalarial action of artemisinin in vitro

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 1, 2010, Pages 148-150

  Mishra, Lokesh C ^a   Bhattacharya, Amit ^a   Sharma, Manish ^a   Bhasin, Virendra K ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ARTEMISININ; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PYRIMETHAMINE; STAVUDINE; SULFADOXINE; ZIDOVUDINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG ANTAGONISM; ENDEMIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; MALARIA FALCIPARUM; MIXED INFECTION; PLASMODIUM FALCIPARUM; MALARIA;

PLASMODIUM FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALARIA; NELFINAVIR;

EID: 74049161945     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0427     Document Type: Article

References (23)

1. WHO, 1998. The Use of Artemisinin and its Derivatives as Antimalarial Drugs. (Report of a joint CTD/DMP/TDR informal consultation.) WHO/MAL/98.1086.
2. White NJ, 2008. Qinghaosu (artemisinin): the price of success. Science 320: 330-334.
3. WHO, 2007. Resistance to artemisinin derivatives along the Thai-Cambodian border. Wkly Epidemiol Rec 82: 360.
4. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF, 2001. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 15: 899-906.
5. Skinner-Adams TS, Andrews KT, Melville L, McCarthy J, Gardiner DL, 2007. Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro Antimicrob Agents Chemother 51: 759-762.
6. Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization, 2005. AIDS Epidemic Update 2005. Available at: www.unaids.org/epi/2005/doc/report-pdf.asp.
7. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, Omoding N, Okongo M, Malamba S, Ojwiya A, 2004. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356: 1051-1056.
8. Abu-Raddad LJ, Patnaik P, Kublin JG, 2006. Dual infection with HIV and malaria fuels the spread of both diseases in Sub-Saharan Africa. Science 314: 1603-1606.
9. Kim HH, Daar ES, 2009. Newer antiretroviral agents and how to use them. Curr HIV/AIDS Rep 6: 55-62.
10. Trager W, Jensen JB, 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
11. Nguyen-Dinh P, Payne D, 1980. Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bull World Health Organ 58: 909-912.
12. Lambros C, Vanderberg JP, 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418-420.
13. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ, 2005. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother 49: 2983-2985.
14. Fivelman QL, Adagu IS, Warhurt DC, 2004. Modified fixed ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother 48: 4097-4102.
15. Bhattacharya A, Mishra LC, Bhasin VK, 2008. In vitro activity of artemisinin in combination with clotrimazole or heat-treated amphotericin B against Plasmodium falciparum. Am J Trop Med Hyg 78: 721-728.
16. Gupta S, Thapar MM, Wemsdorfer WH, Bjorkman A, 2002. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob Agents Chemother 46: 1510-1515.
17. Odds FC, 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52: 1.
18. Chawira AN, Warhurst DC, 1987. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. J Trop Med Hyg 90: 1-8.
19. Department of Health and Human Services and the Henry J. Kaiser Family Foundation, 1998. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med 128: 1079-1100.
20. Bryson YJ, Mirochnick M, Stek A, Mofenson LM, Connor J, Capparelli E, Watts DH, Huang S, Hughes MD, Kaiser K, Purdue L, Asfaw Y, Keller M, Smith E, The PACTG 353 Team, 2008. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials 9: 115-125.
21. Andrews KT, Fairlie DP, Madala PK, Ray J, Wyatt DM, Hilton PM, Melville LA, Beattie L, Gardiner DL, Reid RC, Stoermer MJ, Skinner-Adams T, Berry C, McCarthy JS, 2006. Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother 50: 639-648.
22. Meshnick SR, 1994. The mode of action of antimalarial endoperoxides. Trans R Soc Trop Med Hyg 88: 31-32.
23. Ludwig UE, Webb RJ, van Goethem IDA, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S, 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957-961.